Canopy Growth

CANOPY GROWTH CELEBRATES PASSAGE OF CANNABIS LEGALIZATION IN GERMANY

Retrieved on: 
Friday, March 22, 2024
Growth, International, Vaporizer (inhalation device), Patient, Education, Classification, Cannabis, TSX, Physician, Legislation, Canopy Growth, Drug

SMITHS FALLS, ON, March 22, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, celebrates the German government's final approval legalizing cannabis, as well as advancing a clear victory for enhanced medical cannabis access.

Key Points: 
  • SMITHS FALLS, ON, March 22, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, celebrates the German government's final approval legalizing cannabis, as well as advancing a clear victory for enhanced medical cannabis access.
  • As of April 1, 2024, cannabis will officially be recognized as a non-narcotic in Germany, marking a monumental shift in the legal treatment and cultural acceptance of cannabis.
  • In addition to the cultural significance of Germany's cannabis legalization progress, these changes present a unique opportunity for Canopy Growth to expand its commercial presence in the country through the German-based and world renowned Storz & Bickel vaporizer brand, as well as the Company's medical cannabis product offerings through Canopy Medical which collectively position Canopy Growth as a top three player in the German cannabis industry.
  • For Storz & Bickel, the legalization of recreational cannabis as well as the expected growth of the medical cannabis market in Germany present exciting growth opportunities for the brand's full range of vaporizers.

CANNABIS INDUSTRY MOGULS MEET IN MIAMI FOR BENZINGA CONFERENCE

Retrieved on: 
Tuesday, March 12, 2024
Poseidon, Organization, Conference, Crowe, Growth, Partnership, Minority, Woman, Speech, Medical cannabis, Minority group, Canopy Growth, Drug

HOLLYWOOD, Fla., March 12, 2024 /PRNewswire/ -- The Benzinga Cannabis Capital Conference, North America's premier cannabis investment and branding event, is returning to Florida for a two-day conference starting on April 16, 2024, at The Diplomat Beach Resort in Hollywood. Anchored by keynote speaker Boris Jordan, the event has over 100 CEOs confirmed and is anticipating more than 2,000 attendees.  As one of the most established shows in this industry, the event offers unparalleled opportunities and connections for cannabis entrepreneurs, marketers, and investors to network, learn, and grow within the industry.

Key Points: 
  • HOLLYWOOD, Fla., March 12, 2024 /PRNewswire/ -- The Benzinga Cannabis Capital Conference , North America's premier cannabis investment and branding event, is returning to Florida for a two-day conference starting on April 16, 2024, at The Diplomat Beach Resort in Hollywood.
  • "We have a star-studded conference lineup of active dealmakers and industry luminaries for our return to Florida," says Benzinga CEO Jason Raznick.
  • Our Benzinga Cannabis Capital Conference is the must-attend event of the year for anyone looking to make their mark in the cannabis world.
  • It's the place to meet the biggest industry players and forge deals to drive the global cannabis industry forward."

Vencanna Announces Amended Definitive Agreement with The Cannavative Group, Completion of Name Change, Resumption of Trading and Operational Update

Retrieved on: 
Friday, February 23, 2024
Smoke, University, Senior, Research, Investment, Treasury Wine Estates, CPG, Chase Bank, MillerCoors, HHS, Government, SAFE, Debenture, BID, Physics, LEED AP, Canopy Growth, Controlled Substances Act, Health, CSA, MBA, Gold, CGT, New Jersey Turnpike, IRC, College of Medicine, AB, CPA, TGC, Theoretical physics, FMCG, Fast-moving consumer goods, Rotman School of Management, Final good, Business, Beer, Cannabis, CFO, Acquisition, DEA, Letter, Plastic, ITG, Alcohol, Patient, Partner (business rank), SOP, Security (finance)

Pursuant to the Amended Agreement, Vencanna will acquire all of the outstanding membership units of Cannavative through an all-share exchange.

Key Points: 
  • Pursuant to the Amended Agreement, Vencanna will acquire all of the outstanding membership units of Cannavative through an all-share exchange.
  • The exchangeable securities are exchangeable, at the option of the holder, on a one-for-one basis for equivalent securities of Vencanna.
  • On January 17, 2023, at an annual general and special meeting, the shareholders of Vencanna approved the name change.
  • The Company has engaged Independent Trading Group (ITG) Inc. to act as the broker through which the Bid will be conducted.

CANOPY GROWTH LAUNCHES NEW PRE-ROLLS FROM 7ACRES AND HIWAY

Retrieved on: 
Thursday, February 22, 2024
TSX, Canopy Growth, Burn, Roadie, Cannabis, THC, Tea

SMITHS FALLS, ON, Feb. 22, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced the introduction of five new pre-roll products across the Company's adult-use cannabis portfolio from brands 7ACRES and Hiway.

Key Points: 
  • SMITHS FALLS, ON, Feb. 22, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced the introduction of five new pre-roll products across the Company's adult-use cannabis portfolio from brands 7ACRES and Hiway.
  • "Forging ahead with our commitment to innovation, we're excited to offer new pre-roll offerings that meet consumers across a range of occasions and price points," said Dave Paterson, President, Canada, Canopy Growth.
  • 7ACRES Smooth Burners 2x0.7g cannabis pre-rolls feature a hybrid designed to deliver the smoothest and slowest burn.
  • For those looking for high-quality in a value package, Hiway Water Hash Infused pre-rolls 3x0.5g deliver the goods.

Huxley Health Inc. Provides Corporate Update - Appoints Bruce Linton as Chairman

Retrieved on: 
Tuesday, January 30, 2024
Cardiology, Financial management, Nursing care plan, USD, Neurology, Intellectual property, Canopy Growth, HUX, CAD, Marketing, TSX, Entrepreneurship, Therapy, Acquisition, BIOS, Pharmaceutical industry

TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Huxley Health Inc. (“Huxley” or the “Company”) is pleased to provide you with a comprehensive corporate update, highlighting significant milestones and developments that have shaped Huxley over the past year.

Key Points: 
  • TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Huxley Health Inc. (“Huxley” or the “Company”) is pleased to provide you with a comprehensive corporate update, highlighting significant milestones and developments that have shaped Huxley over the past year.
  • Sintalica has filed four provisional patents for proprietary psychedelic molecules with unique properties, improved stability and safety profiles, and enhanced bioavailability.
  • Bruce Linton is a proven disruptive leader in Technology, Cannabis, and Global Wellness Industries.
  • Bruce currently holds the role as chair of the advisory board of Red Light Holland Corp. (CSE:TRIP)
    “As a Co-Founder and Chairman of Huxley, I’m excited to help steward this innovative company and make a profound impact on healthcare discoveries.” Bruce Linton, Co-Founder and Chairman.

Canopy Growth to Report Third Quarter Fiscal 2024 Financial Results on February 9, 2024

Retrieved on: 
Friday, January 26, 2024
CFO, Webcast, TSX, Eastern Time Zone, Canopy Growth

SMITHS FALLS, ON, Jan. 26, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal year 2024 ended December 31, 2023 before financial markets open on February 9, 2024.

Key Points: 
  • SMITHS FALLS, ON, Jan. 26, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal year 2024 ended December 31, 2023 before financial markets open on February 9, 2024.
  • Following the release of its third quarter fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on February 9, at 10AM Eastern Time.
  • A live audio webcast will be available at: https://app.webinar.net/GZqr9ALP1XV
    A replay will be accessible by webcast until 11:59 PM ET on May 9, 2024 at: https://app.webinar.net/GZqr9ALP1XV

CANOPY GROWTH KICKS OFF THE NEW YEAR WITH NEW PRODUCTS FROM TWEED, 7ACRES, AND SPECTRUM THERAPEUTICS

Retrieved on: 
Wednesday, January 24, 2024
Cream, Therapy, Canopy Growth, GG, Myrcene, Citrus, Oil, Cannabinoid, TSX, Terpene, Lemon meringue pie, CBN, CBG, Phenotype, THC, MCT

"For our medical cannabis consumers, we're proud to continue delivering the variety and convenience that the Spectrum Therapeutics store is synonymous for thanks to new pre-rolls from 7ACRES and the Spectrum Reserve."

Key Points: 
  • "For our medical cannabis consumers, we're proud to continue delivering the variety and convenience that the Spectrum Therapeutics store is synonymous for thanks to new pre-rolls from 7ACRES and the Spectrum Reserve."
  • For consumers not wanting to compromise quality for quantity, Tweed Lemon Meringue Pie is being served up fresh in a large format 28g package.
  • Tweed's Lemon Meringue Pie boasts lemon, citrus and nutty vanilla aromas, is hang-dried, and comes in with a 23-29% THC range.
  • Exclusive for medical cannabis customers, Spectrum Therapeutics is extending its Spectrum Reserve collection with Alien Breath and (GG#4 x Mendo Breath) pre-roll joints.

Hemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025

Retrieved on: 
Thursday, January 11, 2024
Beer, Skin care, Pacific Northwest, CGC, Sale, DSM-IV codes, TLRY, Lead, United States farm bill, Growth, Drink, Food, Sleep, Tilray, CPG, Cosmetics, Uncle, Snack, PALM, ASX, Brink's, Mental health, Acquisition, Cannabis, OTCQX, Tobacco, Marketing, Smoke, Patient, Canopy Growth, Health, Oil, Digital, OTCQB, News, Intellectual property, Drug

A report from The Brightfield Group said: “It is no surprise to see that CBD is expected to grow to $16 billion by 2025.

Key Points: 
  • A report from The Brightfield Group said: “It is no surprise to see that CBD is expected to grow to $16 billion by 2025.
  • Especially as we see people turning to various CBD products for stress management or to promote better sleep.
  • What is most notable is that this market has grown almost exclusively based on word-of-mouth.
  • Canada saw over $3 billion in CBD revenue in 2020 from various products ranging from prerolls, oils, edibles, brinks, and vapes.

Canopy Growth Announces US$30 Million Private Placement

Retrieved on: 
Tuesday, January 9, 2024
Canopy Growth, Unit, Series, Prospectus, Sale, Indian stock exchange, TSX, News, Security (finance)

SMITHS FALLS, ON, Jan. 9, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), today announced that it has entered into subscription agreements (the "Subscription Agreements"), dated as of January 9, 2024, with certain institutional investors (the "Investors") in a private placement offering (the "Offering") of 6,993,007 units ("Units") at a price per Unit of US$4.29 for aggregate gross proceeds of approximately US$30,000,000.

Key Points: 
  • SMITHS FALLS, ON, Jan. 9, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), today announced that it has entered into subscription agreements (the "Subscription Agreements"), dated as of January 9, 2024, with certain institutional investors (the "Investors") in a private placement offering (the "Offering") of 6,993,007 units ("Units") at a price per Unit of US$4.29 for aggregate gross proceeds of approximately US$30,000,000.
  • The purpose of the Offering is to provide the Company with additional liquidity of US$30MM to further strengthen Canopy Growth's financial position.
  • Each Warrant will entitle the holder to acquire one Common Share from the Company at a price equal to US$4.83.
  • The closing of the private placement pursuant to the Subscription Agreements is expected to occur on or about January 10, 2024, subject to customary closing conditions.

Indiva Provides Corporate Update Including Improved Fourth Quarter Revenue Guidance

Retrieved on: 
Thursday, January 4, 2024
Cannabis, Natural Resources, Other Retail, Retail, Tobacco, TSX Venture Exchange, Red One, Plan, Limited, Sale, RSU, Consultant, Indian stock exchange, THC, The Red One, Stock, Growth, Investment, Option, No Future, Automation, Exercise, Canopy Growth, Security (finance)

Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to provide a corporate update and recap of fiscal 2023, including improved quarterly guidance, as the Company now expects record net revenue in the fourth quarter of 2023.

Key Points: 
  • Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to provide a corporate update and recap of fiscal 2023, including improved quarterly guidance, as the Company now expects record net revenue in the fourth quarter of 2023.
  • "Driven by Indiva's best-in-class distribution and store penetration, which exceeds 3,000 stores nationwide, Indiva continues to hold leading market share in the edibles category.
  • Additionally, Indiva has already sold more than two million No Future gummies and over 100,000 No Future vapes since the initial brand launch in B.C.
  • Continued strength in the Pearls by Grön and No Future brands has resulted in fourth quarter 2023 net revenue results, which are set to exceed the initial expectations and guidance provided in our third quarter results press release, dated November 21, 2023.